HIF1A and pancreatic neoplasm: Overexpression of HIF-1α is linked to gemcitabine-resistant pancreatic cancer cells, and its inhibition has been shown to partially reverse epithelial-to-mesenchymal transition (EMT), a process critical to metastasis and drug resistance [5,6].